Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug 23;115(5):624-31.
doi: 10.1038/bjc.2016.228. Epub 2016 Aug 4.

Polyunsaturated Fatty Acids and Prostate Cancer Risk: A Mendelian Randomisation Analysis From the PRACTICAL Consortium

Affiliations
Free PMC article

Polyunsaturated Fatty Acids and Prostate Cancer Risk: A Mendelian Randomisation Analysis From the PRACTICAL Consortium

Nikhil K Khankari et al. Br J Cancer. .
Free PMC article

Abstract

Background: Prostate cancer is a common cancer worldwide with no established modifiable lifestyle factors to guide prevention. The associations between polyunsaturated fatty acids (PUFAs) and prostate cancer risk have been inconsistent. Using Mendelian randomisation, we evaluated associations between PUFAs and prostate cancer risk.

Methods: We used individual-level data from a consortium of 22 721 cases and 23 034 controls of European ancestry. Externally-weighted PUFA-specific polygenic risk scores (wPRSs), with explanatory variation ranging from 0.65 to 33.07%, were constructed and used to evaluate associations with prostate cancer risk per one standard deviation (s.d.) increase in genetically-predicted plasma PUFA levels using multivariable-adjusted unconditional logistic regression.

Results: No overall association was observed between the genetically-predicted PUFAs evaluated in this study and prostate cancer risk. However, risk reductions were observed for short-chain PUFAs, linoleic (ORLA=0.95, 95%CI=0.92, 0.98) and α-linolenic acids (ORALA=0.96, 95%CI=0.93, 0.98), among men <62 years; whereas increased risk was found among men ⩾62 years for LA (ORLA=1.04, 95%CI=1.01, 1.07). For long-chain PUFAs (i.e., arachidonic, eicosapentaenoic, and docosapentaenoic acids), increased risks were observed among men <62 years (ORAA=1.05, 95%CI=1.02, 1.08; OREPA=1.04, 95%CI=1.01, 1.06; ORDPA=1.05, 95%CI=1.02, 1.08).

Conclusion: Results from this study suggest that circulating ω-3 and ω-6 PUFAs may have a different role in the aetiology of early- and late-onset prostate cancer.

Similar articles

  • Mendelian Randomization of Circulating Polyunsaturated Fatty Acids and Colorectal Cancer Risk.
    Khankari NK, Banbury BL, Borges MC, Haycock P, Albanes D, Arndt V, Berndt SI, Bézieau S, Brenner H, Campbell PT, Casey G, Chan AT, Chang-Claude J, Conti DV, Cotterchio M, English DR, Figueiredo JC, Giles GG, Giovannucci EL, Gunter MJ, Hampe J, Hoffmeister M, Hopper JL, Jenkins MA, Joshi AD, Marchand LL, Lemire M, Li CI, Li L, Lindblom A, Martín V, Moreno V, Newcomb PA, Offit K, Pharoah PDP, Rennert G, Sakoda LC, Schafmayer C, Schmit SL, Slattery ML, Song M, Thibodeau SN, Ulrich CM, Weinstein SJ, White E, Win AK, Wolk A, Woods MO, Wu AH, Cai Q, Denny JC, Edwards TL, Murff HJ, Gruber SB, Peters U, Zheng W. Khankari NK, et al. Cancer Epidemiol Biomarkers Prev. 2020 Apr;29(4):860-870. doi: 10.1158/1055-9965.EPI-19-0891. Epub 2020 Feb 12. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 32051193
  • Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis.
    May-Wilson S, Sud A, Law PJ, Palin K, Tuupanen S, Gylfe A, Hänninen UA, Cajuso T, Tanskanen T, Kondelin J, Kaasinen E, Sarin AP, Eriksson JG, Rissanen H, Knekt P, Pukkala E, Jousilahti P, Salomaa V, Ripatti S, Palotie A, Renkonen-Sinisalo L, Lepistö A, Böhm J, Mecklin JP, Al-Tassan NA, Palles C, Farrington SM, Timofeeva MN, Meyer BF, Wakil SM, Campbell H, Smith CG, Idziaszczyk S, Maughan TS, Fisher D, Kerr R, Kerr D, Passarelli MN, Figueiredo JC, Buchanan DD, Win AK, Hopper JL, Jenkins MA, Lindor NM, Newcomb PA, Gallinger S, Conti D, Schumacher F, Casey G, Aaltonen LA, Cheadle JP, Tomlinson IP, Dunlop MG, Houlston RS. May-Wilson S, et al. Eur J Cancer. 2017 Oct;84:228-238. doi: 10.1016/j.ejca.2017.07.034. Epub 2017 Aug 19. Eur J Cancer. 2017. PMID: 28829991 Free PMC article.
  • Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study.
    Forouhi NG, Imamura F, Sharp SJ, Koulman A, Schulze MB, Zheng J, Ye Z, Sluijs I, Guevara M, Huerta JM, Kröger J, Wang LY, Summerhill K, Griffin JL, Feskens EJ, Affret A, Amiano P, Boeing H, Dow C, Fagherazzi G, Franks PW, Gonzalez C, Kaaks R, Key TJ, Khaw KT, Kühn T, Mortensen LM, Nilsson PM, Overvad K, Pala V, Palli D, Panico S, Quirós JR, Rodriguez-Barranco M, Rolandsson O, Sacerdote C, Scalbert A, Slimani N, Spijkerman AM, Tjonneland A, Tormo MJ, Tumino R, van der A DL, van der Schouw YT, Langenberg C, Riboli E, Wareham NJ. Forouhi NG, et al. PLoS Med. 2016 Jul 19;13(7):e1002094. doi: 10.1371/journal.pmed.1002094. eCollection 2016 Jul. PLoS Med. 2016. PMID: 27434045 Free PMC article.
  • Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence.
    Astorg P. Astorg P. Cancer Causes Control. 2004 May;15(4):367-86. doi: 10.1023/B:CACO.0000027498.94238.a3. Cancer Causes Control. 2004. PMID: 15141138 Review.
  • Effect of individual omega-3 fatty acids on the risk of prostate cancer: a systematic review and dose-response meta-analysis of prospective cohort studies.
    Fu YQ, Zheng JS, Yang B, Li D. Fu YQ, et al. J Epidemiol. 2015;25(4):261-74. doi: 10.2188/jea.JE20140120. Epub 2015 Mar 14. J Epidemiol. 2015. PMID: 25787237 Free PMC article. Review.
See all similar articles

Cited by 8 articles

See all "Cited by" articles

References

    1. Ahmad OS, Morris JA, Mujammami M, Forgetta V, Leong A, Li R, Turgeon M, Greenwood CMT, Thanassoulis G, Meigs JB, Sladek R, Richards JB (2015) A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease. Nat Commun 6: 7060. - PMC - PubMed
    1. Alexander DD, Bassett JK, Weed DL, Barrett EC, Watson H, Harris W (2015) Meta-analysis of long-chain omega-3 polyunsaturated fatty acids (LCω-3PUFA) and prostate cancer. Nutr Cancer 67: 543–554. - PMC - PubMed
    1. Arab L (2003) Biomarkers of fat and fatty acid intake. J Nutr 133 (Suppl 3): 925S–932S. - PubMed
    1. Berquin IM, Edwards IJ, Kridel SJ, Chen YQ (2011) Polyunsaturated fatty acid metabolism in prostate cancer. Cancer Metastasis Rev 30: 295–309. - PMC - PubMed
    1. Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44: 512–525. - PMC - PubMed

Publication types

Substances

Feedback